igm-bio-pipeline-hero-11

 

Target/Application Discovery Preclinical Phase 1

CD20 x CD3

NHL and Other B Cell Proliferative Diseases

2019

Death Receptor 5 (DR5)

Solid and Liquid Tumors

2020

PD-L1 x Immune Stimulatory Agent

Solid and Liquid Tumors

2021-2022

OX40

Solid and Liquid Tumors

2021-2022

GITR

Solid and Liquid Tumors

2021-2022